According to the FDA (2024), non-standardized allergenic extracts like Streptococcus pyogenes are regulated as biological products under the Public Health Service Act.
A clinical study published in the Journal of Allergy and Clinical Immunology (2023) emphasizes that beta-blocker use is a major risk factor for patients receiving bacterial antigen immunotherapy.
The World Health Organization (WHO, 2022) notes that while Streptococcus pyogenes is a common pathogen, its use in extracts is limited to specific diagnostic and desensitization protocols.
Data from DailyMed (2024) indicates that Streptococcus pyogenes extracts are typically measured in Protein Nitrogen Units (PNU), where 1 mg of nitrogen equals 100,000 PNU.
The American Academy of Allergy, Asthma & Immunology (AAAAI, 2025) guidelines state that patients must be observed for a minimum of 30 minutes after every injection of a bacterial extract.
According to NIH research (2024), the M-protein in Streptococcus pyogenes is the primary antigen responsible for both its virulence and its effectiveness in stimulating immune response in extracts.
The CDC (2024) clarifies that allergenic extracts containing Streptococcus pyogenes do not cause 'strep throat' as the bacteria are completely inactivated (killed).
A 2023 meta-analysis suggests that bacterial extracts may reduce the frequency of recurrent respiratory infections in certain susceptible populations by 30-40%.
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Streptococcinum, you must consult a qualified healthcare professional.
Streptococcus Pyogenes is a bacterial antigen used primarily in non-standardized allergenic extracts for immunotherapy and diagnostic skin testing. It belongs to the class of inactivated bacterial antigens and allergenic extracts.
💊Usage & Dosage
Adult Dosage
Dosage for Streptococcus pyogenes extracts must be highly individualized based on the patient's sensitivity level and the clinical indication. There is no 'standard' dose for all patients.
For Diagnostic Skin Testing: Typically, 0.02 mL to 0.1 mL of a specific dilution (determined by the physician) is injected intradermally to observe for a wheal and flare reaction (swelling and redness).
For Immunotherapy: Treatment usually begins with a very low dose (e.g., 0.1 mL of a 1:100,000 dilution) and is gradually increased (escalation phase) at weekly intervals until a maintenance dose is reached. A common maintenance dose might range from 0.5 mL of a 1:100 or 1:10 dilution, depending on patient tolerance.
Pediatric Dosage
Streptococcus pyogenes extracts should be used with extreme caution in children.
Approved Use: While not specifically contraindicated in children, the safety and efficacy have not been established in the same rigorous manner as modern pediatric vaccines.
Dosing: Pediatric dosing is generally based on the same titration principles as adult dosing but often starts at even lower concentrations to minimize the risk of systemic reactions. Healthcare providers will monitor growth and developmental milestones during long-term immunotherapy.
Dosage Adjustments
Renal Impairment
No specific dosage adjustments are required for patients with kidney disease, as the antigens are not primarily cleared by the kidneys. However, the patient's overall health status must be considered.
Hepatic Impairment
No dosage adjustments are established for liver impairment. The metabolic processing of bacterial antigens occurs in the immune cells rather than the liver parenchyma.
Elderly Patients
Geriatric patients may have a diminished immune response (immunosenescence), which can lead to false-negative skin tests. Dosing should be approached conservatively, starting at the lowest possible concentration.
How to Take Streptococcus Pyogenes
Streptococcus pyogenes extracts are strictly for professional administration. They are never for self-administration at home.
1Administration Route: Usually administered via subcutaneous injection in the outer aspect of the upper arm. Intradermal injection is reserved for diagnostic testing.
2Observation Period: Patients must remain in the doctor's office for at least 30 minutes following an injection. This is the period of highest risk for a life-threatening allergic reaction (anaphylaxis).
3Site Rotation: Injection sites should be rotated to prevent local tissue hardening (induration) or irritation.
4Storage: Vials must be stored in a refrigerator (2°C to 8°C or 36°F to 46°F). They must never be frozen. If the solution appears cloudy or contains unexpected particles, it should be discarded.
Missed Dose
If a dose in an immunotherapy schedule is missed, the next dose may need to be reduced.
Short Delay (1-2 weeks): The doctor may repeat the last dose.
Long Delay (over 4 weeks): The doctor may need to restart the titration from a much lower concentration to avoid a 'rebound' sensitivity reaction.
Overdose
An overdose of Streptococcus pyogenes extract usually manifests as an exaggerated allergic response.
Symptoms: Large local swelling (greater than 10 cm), hives (urticaria), shortness of breath, or a drop in blood pressure.
Emergency Measures: Administration of epinephrine (Adrenalin) is the primary treatment for a systemic overdose. Patients should be transported to an emergency department immediately if a systemic reaction occurs.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or frequency without medical guidance, as this increases the risk of severe allergic reactions.
⚠️Side Effects
Common Side Effects (>1 in 10)
Most patients receiving Streptococcus pyogenes extracts will experience some form of local reaction. These are generally considered a sign that the immune system is responding to the antigen.
Injection Site Erythema: Redness at the site of injection is very common. It usually appears within minutes and may last for several hours.
Wheal and Flare: A raised, itchy bump (wheal) surrounded by redness (flare). This is the expected result of a skin test but can also occur during immunotherapy.
Local Pruritus: Intense itching at the injection site. This typically peaks within 30-60 minutes post-injection.
Induration: A hardening of the skin at the injection site that may develop 24 to 48 hours later (delayed-type hypersensitivity).
🔴Warnings
Important Safety Information
Streptococcus pyogenes extracts are biological products that carry inherent risks. They are not 'vaccines' in the modern sense (like the flu shot) but are antigenic stimulants. Patients must be fully informed of the risks of immunotherapy before beginning treatment.
Black Box Warnings
No specific FDA black box warning exists for Streptococcus Pyogenes as a standalone ingredient, but it falls under the mandatory class warning for Allergenic Extracts:
Anaphylaxis Risk: Severe, life-threatening allergic reactions can occur.
Supervision: Must be administered in a clinical setting with emergency equipment (epinephrine, oxygen, airway management) available.
Asthma Warning: Patients with severe or poorly controlled asthma should not receive these extracts due to the risk of fatal bronchospasm.
🔄Interactions
Contraindicated Combinations (Do Not Use Together)
Beta-Blockers (e.g., Propranolol, Atenolol, Metoprolol): Patients taking beta-blockers should generally not receive allergenic extracts. Reason: If the patient has an anaphylactic reaction, beta-blockers make epinephrine (the primary treatment) significantly less effective. This can lead to treatment-resistant, fatal anaphylaxis.
Serious Interactions (Monitor Closely)
ACE Inhibitors (e.g., Lisinopril, Enalapril): These drugs may increase the risk of systemic reactions or worsen the severity of angioedema (swelling) during immunotherapy.
Immunosuppressants (e.g., Cyclosporine, Methotrexate, Prednisone): These medications may blunt the immune system's response to the extract, making the treatment less effective or the skin test results inaccurate.
🚫Contraindications
Absolute Contraindications
Streptococcus pyogenes extracts must NEVER be used in the following circumstances:
1Severe, Uncontrolled Asthma: Patients with a forced expiratory volume (FEV1) consistently below 70% of predicted are at extreme risk for fatal bronchospasm during a systemic reaction.
2Previous Severe Systemic Reaction: If a patient has previously experienced anaphylaxis or a life-threatening response to this specific extract.
3Acute Infection: Administration during an active febrile illness can lead to severe systemic inflammatory responses.
4Recent Myocardial Infarction (Heart Attack)
👥Special Populations
Pregnancy
FDA Pregnancy Category: Not formally assigned (often treated as Category C).
Risks: There is no evidence that Streptococcus pyogenes antigens are teratogenic (cause birth defects). However, the primary risk to the fetus is maternal anaphylaxis, which can lead to uterine contractions, placental hypoxia (lack of oxygen), and fetal death.
Clinical Guidance: Most allergists recommend continuing maintenance doses during pregnancy if they are well-tolerated, but they strongly advise against increasing the dose or starting new therapy during pregnancy.
Breastfeeding
Passage into Milk: It is highly unlikely that the bacterial antigens pass into breast milk in any significant or active form.
🧬Pharmacology
Mechanism of Action
Streptococcus pyogenes extracts function as immunomodulators. The extract contains a complex mixture of bacterial antigens, including M-proteins, lipoteichoic acids, and various enzymes (e.g., streptolysins).
1Antigen Presentation: Upon injection, these proteins are captured by dendritic cells in the dermis or subcutaneous tissue.
2T-Cell Modulation: The antigens are presented to naive T-cells. Repeated exposure promotes the differentiation of T-regulatory (Treg) cells. These cells produce IL-10, which inhibits the allergic Th2 response.
3B-Cell Switch: The immune system is signaled to switch production from IgE (the allergy antibody) to IgG4 (the 'blocking' antibody). IgG4 can intercept the bacterial antigens before they can bind to IgE on mast cells, preventing the release of histamine.
Frequently Asked Questions
Common questions about Streptococcinum
What is Streptococcus Pyogenes used for?
Streptococcus Pyogenes extract is primarily used in clinical immunology for diagnostic skin testing and allergen immunotherapy. In skin testing, it helps healthcare providers determine if a patient's cellular immune system is functioning correctly by observing for a physical reaction. In immunotherapy, it is used to desensitize patients who have hypersensitivity to bacterial proteins or to stimulate a general immune response against recurrent infections. It is often part of a 'non-standardized' group of extracts, meaning it is used in specialized cases under the guidance of an allergist or immunologist. It is not used to treat active strep throat infections.
What are the most common side effects of Streptococcus Pyogenes?
The most common side effects are localized to the site of the injection and include redness, swelling, itching, and a raised bump known as a wheal. These reactions typically appear within minutes of the injection and usually resolve within 24 hours. Some patients may also experience a 'delayed' reaction where the area becomes hard and warm to the touch a day or two later. While these local reactions are common and usually mild, they must be monitored because a very large local reaction can sometimes predict a more serious systemic reaction in the future. Always report any significant swelling to your doctor.
Can I drink alcohol while taking Streptococcus Pyogenes?
It is generally advised to avoid alcohol consumption on the day of your Streptococcus Pyogenes injection. Alcohol causes the blood vessels to dilate, which can potentially speed up the absorption of the bacterial antigens into your bloodstream, increasing the risk of a systemic allergic reaction. Furthermore, alcohol can mask early symptoms of anaphylaxis, such as flushing or lightheadedness, making it harder for you or your doctor to recognize an emergency. To ensure maximum safety during the observation period and the hours following your treatment, it is best to remain sober. Always consult your physician for specific guidance regarding your lifestyle and treatment.
Is Streptococcus Pyogenes safe during pregnancy?
The safety of Streptococcus Pyogenes extracts during pregnancy is a complex issue that requires a detailed discussion with your healthcare provider. While the antigens themselves are not known to cause birth defects, the risk of a severe allergic reaction (anaphylaxis) in the mother poses a significant danger to the fetus by potentially cutting off its oxygen supply. Most medical guidelines suggest that if a woman is already on a stable maintenance dose and tolerating it well, the treatment may be continued. However, starting new therapy or increasing the dosage is generally avoided during pregnancy to minimize risks. Your doctor will perform a risk-benefit analysis based on your specific health needs.
How long does it take for Streptococcus Pyogenes to work?
The timeline for the effectiveness of Streptococcus Pyogenes depends on whether it is being used for testing or treatment. For diagnostic skin testing, the results are immediate, with the reaction appearing within 15 to 30 minutes. For therapeutic immunotherapy, the process is much slower; it involves an escalation phase where doses are gradually increased over several months. Most patients do not see a significant change in their immune reactivity or a reduction in symptoms until they have reached their maintenance dose, which typically takes 3 to 6 months of consistent weekly injections. Long-term success usually requires staying on the treatment for 3 to 5 years.
Can I stop taking Streptococcus Pyogenes suddenly?
While you can physically stop the injections at any time, doing so will cause your immune system to lose the 'tolerance' it has built up toward the antigens. If you stop the treatment for more than a few weeks and then try to resume at the same dose, you are at a very high risk for a severe allergic reaction. If you must interrupt your treatment due to illness or travel, your doctor will need to adjust your next dose downward to safely restart the process. It is important to follow a planned schedule and never attempt to 'catch up' on missed doses by taking more at once.
What should I do if I miss a dose of Streptococcus Pyogenes?
If you miss a dose of your Streptococcus Pyogenes extract, you should contact your allergist's office immediately to reschedule. Do not simply wait until your next regular appointment without calling. The management of a missed dose depends on how long it has been since your last injection; if only a few days have passed, you may be able to continue as planned. However, if several weeks have passed, your doctor will likely need to reduce the dose for your next injection to ensure your safety. Consistency is key to the success of immunotherapy, so try to maintain a regular schedule.
Does Streptococcus Pyogenes cause weight gain?
There is no clinical evidence to suggest that Streptococcus Pyogenes extracts cause weight gain. Unlike systemic corticosteroids (like prednisone), which are known to affect metabolism and appetite, bacterial extracts work locally and through specific immune pathways that do not involve fat storage or metabolic rate changes. If you experience unexpected weight gain while undergoing immunotherapy, it is likely due to other factors or medications. You should discuss any changes in your weight or overall health with your primary care physician to identify the underlying cause.
Can Streptococcus Pyogenes be taken with other medications?
Streptococcus Pyogenes can interact with several types of medications, some of which can make the treatment dangerous. The most critical interactions are with beta-blockers, which are used for heart conditions and migraines, as they can prevent life-saving treatments from working if you have an allergic reaction. Other medications like antihistamines can interfere with the results of skin tests by hiding the reaction. You must provide your doctor with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you are taking. Your healthcare provider will determine if any of these need to be adjusted before you begin your injections.
Is Streptococcus Pyogenes available as a generic?
The concept of 'generic' is different for biological products like Streptococcus Pyogenes extracts. Because these are non-standardized extracts derived from living organisms, no two manufacturers' products are exactly identical. While different companies may produce Streptococcus Pyogenes extracts, they are not considered interchangeable 'generics' in the way that ibuprofen tablets are. If your pharmacy or doctor changes the brand of extract you are using, they must treat it as a new medication and may need to lower your dose to ensure you do not have an adverse reaction to the new formulation.
Similar Medications
Other drugs with the same active ingredient (Streptococcus Pyogenes)
Low-grade Fever: Some patients may experience a slight increase in body temperature as the immune system is stimulated.
Malaise: A general feeling of discomfort or tiredness following the injection.
Lymphadenopathy: Swelling of the lymph nodes near the injection site (e.g., under the arm).
Headache: Mild to moderate headaches have been reported following bacterial antigen administration.
Rare Side Effects (less than 1 in 100)
Arthus Reaction: A localized vasculitis (inflammation of blood vessels) caused by the deposition of antigen-antibody complexes. It presents as severe pain, swelling, and sometimes tissue necrosis (death) at the injection site.
Urticaria (Hives): Generalized itching and hives across the body, indicating a systemic rather than local response.
Angioedema: Swelling of the deeper layers of the skin, often around the eyes or lips.
Serious Side Effects — Seek Immediate Medical Attention
> Warning: Stop taking Streptococcus Pyogenes and call your doctor immediately or seek emergency care if you experience any of the following symptoms of anaphylaxis:
1Difficulty Breathing: Wheezing, chest tightness, or a feeling that the throat is closing.
2Hypotension: A sudden drop in blood pressure, which may feel like dizziness, lightheadedness, or fainting.
3Rapid Pulse: A racing heart rate (tachycardia) accompanied by cold, clammy skin.
4Cyanosis: A bluish tint to the lips, face, or fingernails, indicating lack of oxygen.
5Seizures: Though extremely rare, systemic toxicity can lead to neurological symptoms.
Long-Term Side Effects
With prolonged immunotherapy using Streptococcus pyogenes extracts, there is a theoretical risk of developing autoimmune-like symptoms. Because S. pyogenes is associated with rheumatic fever (an autoimmune response to bacterial M-protein), long-term use requires monitoring for joint pain, heart murmurs, or unusual rashes. However, since the extracts use inactivated antigens and are highly purified, the risk of triggering rheumatic fever is considered clinically negligible, though not zero.
Black Box Warnings
While Streptococcus pyogenes extracts may not always carry a specific 'Black Box' on every label, the FDA requires a general warning for all allergenic extracts regarding Anaphylaxis.
Summary: This product can cause life-threatening systemic allergic reactions. It must only be administered by healthcare providers prepared to treat anaphylaxis. Patients with unstable asthma are at a significantly higher risk of fatal reactions.
Report any unusual symptoms or persistent reactions to your healthcare provider. Even a large local reaction should be reported, as it may be a precursor to a systemic reaction at the next dose.
Major Precautions
Allergic Reactions / Anaphylaxis Risk: This is the primary concern. Reactions can occur even in patients who have previously tolerated the extract. The risk is higher during the 'escalation phase' of dosing.
Infection Risk: Do not administer the extract if the patient has an active fever or infection. This can prime the immune system to overreact to the antigen.
Autoimmune History: Use with caution in patients with a history of post-streptococcal complications, such as Acute Rheumatic Fever (ARF) or Post-Streptococcal Glomerulonephritis (PSGN). Although the antigens are inactivated, the theoretical risk of molecular mimicry exists.
Bleeding Disorders: Use caution in patients with thrombocytopenia (low platelets) or those on anticoagulants, as the injection may cause significant bruising or hematoma.
Monitoring Requirements
Patients undergoing long-term treatment should have the following monitored:
1Peak Flow/Lung Function: For patients with a history of asthma.
2Injection Site Assessment: To check for large delayed reactions (Arthus reactions).
3Vital Signs: Blood pressure and heart rate should be checked if the patient feels unwell after a dose.
Driving and Operating Machinery
Generally, Streptococcus pyogenes does not affect the ability to drive. However, if a patient experiences a systemic reaction (dizziness, drop in blood pressure), they should not operate machinery until cleared by a doctor.
Alcohol Use
Alcohol should be avoided on the day of the injection. Alcohol can cause vasodilation (widening of blood vessels), which may increase the rate of antigen absorption and potentially mask the early signs of an allergic reaction.
Discontinuation
If treatment is discontinued for more than a few weeks, the patient loses their 'tolerance.' Resuming treatment at the previous maintenance dose can be dangerous. A 'taper-up' or restart protocol is mandatory.
> Important: Discuss all your medical conditions, especially heart or lung problems, with your healthcare provider before starting Streptococcus Pyogenes.
MAO Inhibitors (e.g., Phenelzine): May potentiate the effects of epinephrine if it needs to be administered for a reaction, leading to hypertensive crisis.
Moderate Interactions
Antihistamines (e.g., Loratadine, Cetirizine): These will suppress the 'wheal and flare' response. Patients must stop taking antihistamines for 3 to 7 days before diagnostic skin testing to ensure accurate results.
Tricyclic Antidepressants (e.g., Amitriptyline): Similar to MAOIs, these can interfere with the body's response to emergency medications like epinephrine.
Food Interactions
General Food Allergies: If a patient is having an active allergic reaction to a food, they should not receive a Streptococcus pyogenes injection that day, as their 'allergic threshold' is already lowered.
Caffeine: High doses of caffeine may increase heart rate, which can complicate the monitoring of a systemic reaction.
Herbal/Supplement Interactions
St. John's Wort: May interact with various medications used to treat allergic reactions.
Immune-Stimulating Herbs (e.g., Echinacea, Astragalus): There is a theoretical risk that these could cause an unpredictable immune response when combined with bacterial antigens.
Lab Test Interactions
Skin Tests for Other Allergens: Streptococcus pyogenes extract can cause local inflammation that might interfere with the reading of adjacent skin tests (the 'angry back' syndrome).
TB Tests (PPD): Viral or bacterial extracts can sometimes cause temporary suppression of the reaction to a Tuberculin skin test.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Even over-the-counter allergy pills can change how you react to this treatment.
: The stress of a potential allergic reaction or the administration of epinephrine could be fatal in patients with unstable cardiac disease.
Relative Contraindications
Conditions requiring a careful risk-benefit analysis by a specialist:
Autoimmune Diseases: Such as Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis, as immunostimulation might trigger a flare-up of the underlying condition.
Pregnancy: While not an absolute contraindication for maintenance therapy, starting a new escalation of Streptococcus pyogenes during pregnancy is generally avoided.
Beta-Blocker Therapy: If the beta-blocker cannot be safely discontinued, immunotherapy is usually withheld.
Cross-Sensitivity
Patients who are highly sensitive to other Gram-positive bacteria (like Staphylococcus) may show increased sensitivity to Streptococcus pyogenes extracts. There is also a theoretical cross-reactivity with certain human tissues (molecular mimicry), which is why a history of rheumatic heart disease is a significant red flag for healthcare providers.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of heart disease or autoimmune disorders, before prescribing Streptococcus Pyogenes.
Safety: Breastfeeding is generally considered safe while receiving these extracts. There are no known adverse effects on the nursing infant.
Pediatric Use
Safety: Use in children under the age of 5 is generally avoided because they may be unable to clearly communicate the early symptoms of a systemic reaction.
Efficacy: Immunotherapy is effective in children, but the risk of large local reactions is higher. Monitoring for any interference with normal growth or the development of post-streptococcal sequelae is advised.
Geriatric Use
Risk Profile: Older adults are more likely to have underlying cardiovascular disease, which makes them poorer candidates for treating anaphylaxis (e.g., they may not tolerate epinephrine well).
Dosing: Start with the lowest possible dose. The skin's reactivity decreases with age, so diagnostic tests may be less reliable.
Renal Impairment
Patients with end-stage renal disease (ESRD) or those on dialysis may have altered immune function. While the drug itself is not nephrotoxic, the immune response may be unpredictable. No specific GFR-based adjustments exist, but clinical monitoring should be intensified.
Hepatic Impairment
There are no known issues with using Streptococcus pyogenes extracts in patients with liver disease. The processing of the antigens is independent of hepatic metabolic pathways.
> Important: Special populations require individualized medical assessment. Always inform your specialist if you become pregnant or develop new health problems during treatment.
Pharmacodynamics
Onset of Action: For skin testing, the onset is 15-30 minutes (immediate hypersensitivity). For immunotherapy, the clinical effect (reduction in symptoms) may take 3 to 6 months of regular injections.
Duration of Effect: The immunologic 'memory' created by the extract can last for years, though maintenance injections are typically required every 2 to 4 weeks to sustain the effect.
Tolerance: The goal of therapy is the development of 'immunological tolerance,' where the body no longer perceives the bacterial proteins as a threat.
Pharmacokinetics
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Local absorption) |
| Protein Binding | N/A (Particulate antigen) |
| Half-life | Days (Antigen persistence in lymph) |
| Tmax | 1-2 hours (Systemic absorption) |
| Metabolism | Cellular Proteolysis |
| Excretion | Not renally excreted |
Chemical Information
Composition: A sterile aqueous extract of killed Streptococcus pyogenes cells. It contains soluble and insoluble cellular components.
Solubility: Soluble in physiological saline solutions.
Molecular Weight: Variable (mixture of proteins ranging from 10 kDa to >200 kDa).
Drug Class
Streptococcus pyogenes is classified as a Non-Standardized Allergenic Extract. It is related to other bacterial extracts like Staphylococcus aureus and Haemophilus influenzae extracts, which were historically used in mixed bacterial vaccines.